|
Status |
Public on Aug 01, 2024 |
Title |
Gene expression changes in mouse breast cancer cells (4T1) after axitinib resistance and FACS isolation of SA-β-galHi (SM+) and SA-β-galLo (SM-) cells |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
RNA sequencing analysis was used to identify changes in mouse breast cancer cells (4T1) after axitinib resistance and FACS isolation of SA-β-galHi (SM+) and SA-β-galLo (SM-) cells
|
|
|
Overall design |
Mouse breast cancer cells (4T1) resistant to axitinib were derived in vivo after continuous treatment with 100mg/kg/day axitinib from post-surgical lesions. Resistant cells were maintained in vitro with 0.5µM axitinib for more than 2 months. Resistant cells were stained for fluorescent SA-β-gal substrate C12FDG and fractioned into SA-β-galHi (SM+) and SA-β-galLo (SM-) populations
|
|
|
Contributor(s) |
Long M, Dolan M, Ebos JM |
Citation(s) |
38896060 |
|
Submission date |
Feb 27, 2023 |
Last update date |
Aug 01, 2024 |
Contact name |
Mark D Long |
E-mail(s) |
mark.long@roswellpark.org
|
Organization name |
Roswell Park Comprehensive Cancer Center
|
Department |
Bioinformatics & Biostatistics
|
Street address |
Elm & Carlton Streets
|
City |
Buffalo |
State/province |
NY |
ZIP/Postal code |
14263 |
Country |
USA |
|
|
Platforms (1) |
GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
|
Samples (6)
|
|
Relations |
BioProject |
PRJNA939225 |